Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 04, 2015 8:44 PM ET


Company Overview of Protea Biosciences Group, Inc

Company Overview

Protea Biosciences Group, Inc., molecular information company, develops and commercializes proprietary life science technologies, products, and services to identify the molecules that are produced by living cells and various life forms. The company provides molecular information services for the identification of small and large molecules; and tissue analytics services to create tissue-based molecular profiles. It also offers laser ablation electrospray ionization, a bioanalytical instrument platform that enables the identification of proteins, lipids, and metabolites in tissue, cells, and biofluids, such as serum and urine with minimal or without any sample preparation prior to analysis. It...

955 Hartman Run Road

Morgantown, WV 26507

United States

Founded in 2001

39 Employees





Key Executives for Protea Biosciences Group, Inc

Chairman, Chief Executive Officer and President
Age: 68
Total Annual Compensation: $240.0K
Chief Financial Officer
Age: 60
Total Annual Compensation: $145.6K
Vice President of Operations
Age: 45
Total Annual Compensation: $210.0K
Chief Science Officer and Vice President of Research & Development
Age: 39
Total Annual Compensation: $153.9K
Vice President of Corporate Finance and Development
Age: 28
Total Annual Compensation: $131.0K
Compensation as of Fiscal Year 2014.

Protea Biosciences Group, Inc Key Developments

Protea Biosciences Group, Inc Announces Board Appointments

Effective April 17, 2015, Maged Shenouda and Patrick Gallagher were appointed by the board of directors of Protea Biosciences Group Inc. to serve as directors to fill existing vacancies on the Board. Maged Shenouda has over 25 years of experience in the pharmaceutical and securities industries. Most recently, Mr. Shenouda was the Head of Business Development and Licensing at Retrophin Inc. Patrick Gallagher, CFA, is an accomplished Capital Markets executive, advisor and investor with a distinguished record of success in both the public and private markets with a focus on healthcare, agriculture and industrials. He is a Managing Director and Head of Institutional Sales for Laidlaw & Company (UK) Ltd. Mr. Gallagher sits on the board of directors for BioSig Technologies Inc.

Protea Biosciences Group, Inc. Announces Board Resignations

On March 25, 2015, Andrew Zulauf resigned as a Director of Protea Biosciences Group Inc. On March 31, 2015, Roderick Jackson resigned as a Director of the company.

Protea Biosciences Group, Inc Auditor Raises 'Going Concern' Doubt

Protea Biosciences Group, Inc filed its 10-K on Feb 13, 2015 for the period ending Dec 31, 2014. In this report its auditor, Schneider Downs & Co., Inc., gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Similar Private Companies By Industry

Company Name Region
Center Of Research Technology & Entrepreneurial Expertise United States
EyeCyte, Inc. United States
RaNA Therapeutics, Inc. United States
Lux Biosciences, Inc. United States
Neurop, Inc. United States

Recent Private Companies Transactions

April 6, 2015
vivoPharm Pty.Ltd.
Private Placement
October 31, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Protea Biosciences Group, Inc, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at